1. Home
  2. GSIT vs ALXO Comparison

GSIT vs ALXO Comparison

Compare GSIT & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSIT
  • ALXO
  • Stock Information
  • Founded
  • GSIT 1995
  • ALXO 2015
  • Country
  • GSIT United States
  • ALXO United States
  • Employees
  • GSIT N/A
  • ALXO N/A
  • Industry
  • GSIT Semiconductors
  • ALXO Biotechnology: Pharmaceutical Preparations
  • Sector
  • GSIT Technology
  • ALXO Health Care
  • Exchange
  • GSIT Nasdaq
  • ALXO Nasdaq
  • Market Cap
  • GSIT 74.5M
  • ALXO 76.5M
  • IPO Year
  • GSIT N/A
  • ALXO 2020
  • Fundamental
  • Price
  • GSIT $3.20
  • ALXO $1.99
  • Analyst Decision
  • GSIT
  • ALXO Strong Buy
  • Analyst Count
  • GSIT 0
  • ALXO 5
  • Target Price
  • GSIT N/A
  • ALXO $13.25
  • AVG Volume (30 Days)
  • GSIT 135.1K
  • ALXO 1.1M
  • Earning Date
  • GSIT 01-23-2025
  • ALXO 11-07-2024
  • Dividend Yield
  • GSIT N/A
  • ALXO N/A
  • EPS Growth
  • GSIT N/A
  • ALXO N/A
  • EPS
  • GSIT N/A
  • ALXO N/A
  • Revenue
  • GSIT $19,691,000.00
  • ALXO N/A
  • Revenue This Year
  • GSIT N/A
  • ALXO N/A
  • Revenue Next Year
  • GSIT N/A
  • ALXO N/A
  • P/E Ratio
  • GSIT N/A
  • ALXO N/A
  • Revenue Growth
  • GSIT N/A
  • ALXO N/A
  • 52 Week Low
  • GSIT $1.88
  • ALXO $1.19
  • 52 Week High
  • GSIT $6.02
  • ALXO $17.83
  • Technical
  • Relative Strength Index (RSI)
  • GSIT 47.13
  • ALXO 60.32
  • Support Level
  • GSIT $2.54
  • ALXO $1.40
  • Resistance Level
  • GSIT $3.12
  • ALXO $1.88
  • Average True Range (ATR)
  • GSIT 0.16
  • ALXO 0.19
  • MACD
  • GSIT -0.01
  • ALXO 0.02
  • Stochastic Oscillator
  • GSIT 35.42
  • ALXO 81.15

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: